Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
Warm weather bringing more ticks to the suburbs
As warmer weather arrives and more folks enjoy the outdoors, suburban health experts warn residents to... -
Schaumburg commemorates National Police Week with ceremony honoring fallen officers
Present and past members of the Schaumburg Police Department were joined Monday by other village officials... -
Chiropractor accused of sexually abusing 2 teen patients
An Aurora chiropractor has been charged with sexually abusing two teenage patients.